Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03601117 · ClinicalTrials.gov registry record · NA
Accelerated Intermittent Theta Burst Stimulation for Depressive Symptoms
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 23
- Enrollment target
NCT03601117: Completed NA study, sponsored by Stanford University.
NCT03601117 is a NA study that has completed, run by Stanford University. The registered enrollment target is 23 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03601117, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 23 participants
- Enrollment target
Study Summary
This study evaluates an accelerated schedule of theta-burst stimulation for depressive symptoms in psychiatric inpatients. A small pilot study (n=22) will be carried out to demonstrate feasibility, using the FDA-approved stimulation site for depression treatment (L-DLPFC). Participants will be offered stimulation at the anterior cingulate cortex (ACC).
Interventions
- DEVICE Dorsolateral Prefrontal Cortex Accelerated Theta Burst Stimulation
- DEVICE Anterior Cingulate Cortex Accelerated Theta Burst Stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2018-07-01 |
| Est. Completion | 2020-06-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03601117
The ClinicalTrials.gov registry entry for NCT03601117 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Dorsolateral Prefrontal Cortex Accelerated Theta Burst Stimulation is the first listed.
NCT03601117 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03601117 about?
NCT03601117 is a clinical study titled "Accelerated Intermittent Theta Burst Stimulation for Depressive Symptoms". This study evaluates an accelerated schedule of theta-burst stimulation for depressive symptoms in psychiatric inpatients. A small pilot study (n=22) will be carried out to demonstrate feasibility, using the FDA-approved stimulation site for depression treatment (L-DLPFC). Participants will be offe...
What is the current status of trial NCT03601117?
This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2018-07-01. Estimated completion is 2020-06-01.
What interventions are being tested in trial NCT03601117?
The interventions under investigation include: Dorsolateral Prefrontal Cortex Accelerated Theta Burst Stimulation (DEVICE), Anterior Cingulate Cortex Accelerated Theta Burst Stimulation (DEVICE).
Who is sponsoring clinical trial NCT03601117?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.